Beck, C and Lavelle, RB (2001). Feline polycystic kidney disease in Persian and other cats: a prospective study using ultrasonography. Aust. Vet. J., 79: 181-184.
Cannon, MJ; Barr, FJ; Rudorf, H; Bradley, KJ; Gruffydd-Jones, TJ and MacKay, AD (2001). Prevalence of polycystic kidney disease in Persian cats in the United Kingdom. Vet. Rec., 149: 409-411.
Chapman, AB (2007). Autosomal dominant polycystic kidney disease: time for a change? J. Am. Soc. Nephrol., 18: 1399-1407.
Domanjko-Petric, A; Cernec, D and Cotman, M (2008). Polycystic kidney disease: a review and occurrence in Slovenia with comparison between ultrasound and genetic testing. J. Feline Med. Surg., 10: 115-119.
Eaton, KA; Biller, DS; DiBartola, SP; Radin, MJ and Wellman, ML (1997). Autosomal dominant polycystic kidney disease in Persian and Persian-cross cats. Vet. Pathol., 34: 117-126.
Guerra, JM; Freitas, MF; Daniel, AGT; Pellegrino, A; Cardoso, NC; de Castro, I; Onuchic, LF and Cogliati, B (2018). Age-based ultrasonographic criteria for diagnosis of autosomal dominant polycystic kidney disease in Persian cats. J. Feline Med. Surg., 21: 156-164.
Iglesias, CG; Torres, VE; Offord, KP; Holley, KE; Beard, CM and Kurland, LT (1983). Epidemiology of adult
polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am. J. Kidney Dis., 2: 630-639.
Miller, RH; Lehmkuhl, LB; Smeak, DD; DiBartola, SP and Radin, J (1999). Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease. Am. J. Vet. Res., 60: 1516-1525.
Norman, J (2011). Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim. Biophys. Acta. 1812: 1327-1336.
Paryan, M; Tavakoli, R; Rad, S; Feizi, N; Kamani, F; Mostafavi, E and Mohammadi-Yeganeh, S (2016). Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma. 3 Biotech. 6: 58.